Technological advancements are largely responsible for the movement of higher acuity cases into the outpatient setting. William Wilder, director of DePuy Synthes Advantage Field Solutions, discusses ...
NEW BRUNSWICK, N.J. and WEST CHESTER, Pa., April 27, 2011 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ), the world's most comprehensive and broadly-based manufacturer of health care products, and ...
A blockbuster international deal announced Wednesday, in which New Jersey-based health products giant Johnson & Johnson has agreed to buy medical device maker Synthes for $21.3 billion, could have a ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. DePuy Synthes received FDA 510(k) clearance for its ...
WEST CHESTER, Pa. and INDIANAPOLIS, June 9, 2011 /PRNewswire/ -- Synthes, Inc. (SIX: SYST.VX) and Eli Lilly and Company (NYSE: LLY) today announced the signing of an exclusive worldwide collaboration ...
EAST GOSHEN – U.S. regulators warned Swiss medical device maker Synthes Inc. about violations at its Brandywine plant on Goshen Parkway and said the company may have to pay a fine if it fails to fix ...
ZURICH, Sept 26 (Reuters) - Swiss medical device maker Synthes repeated on Wednesday it expects sales to grow by a low double-digit percentage figure this year. The company expects to achieve this ...
ZURICH/NEW YORK (Reuters) - Synthes Inc confirmed it was in merger talks with Johnson & Johnson about a deal that would be J&J's largest-ever acquisition and reshape the medical devices industry. A ...
Kuros Biosurgery AG, a biotechnology company focused on the development of novel biomaterials and bioactive-biomaterial combination products for trauma, wound and spinal indications has signed a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback